Side-by-side comparison of AI visibility scores, market position, and capabilities
Indian Bitcoin cashback rewards platform for everyday purchases; $4.82M from Accel and YC with 700K users earning satoshis while shopping competing in India's constrained crypto market.
GoSats is a Bengaluru-based rewards platform that enables Indian consumers to earn Bitcoin cashback on everyday purchases — providing a mobile app and SatsPay feature that converts a percentage of qualifying purchases (food delivery, fashion, entertainment) into Bitcoin satoshis deposited in the user's GoSats wallet. Founded in 2019 and backed by $4.82 million from Accel and Y Combinator, GoSats surpassed 700,000 users in October 2024 and generated ₹9.11 crore (~$1.1 million) in revenue, making Bitcoin accumulation accessible to Indian consumers who don't have the technical knowledge to directly purchase cryptocurrency.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.